Megace and condition aggravated Patient Reports February 12, 2012

Megace Side Effects Report #5127389-2
Megace side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, 78 years of age, weighting 133.0 lb, was diagnosed with weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: acidosis, asthenia, condition aggravated, cystitis escherichia, enterocutaneous fistula, escherichia sepsis, renal failure. Megace dosage: 800MG DAILY PO. Patient was hospitalized. Patient recovered.

Megace Side Effects Report #5272196-3
Megace side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2007. Female patient, 71 years of age, weighting 178.0 lb, was diagnosed with weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: chronic obstructive pulmonary disease, condition aggravated, dysphagia. Megace dosage: 20ML PO QD. During the same period patient was treated with FENTANYL, PROCHLORPERAZINE. Patient was hospitalized. Patient recovered.

Megace Side Effects Report #5305648-8
Megace side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient, weighting 122.0 lb, was diagnosed with pancreatic carcinoma metastatic, weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, back pain , condition aggravated, decreased appetite, deep vein thrombosis , fatigue, fluid overload, oedema peripheral. Megace dosage: 800 MG QDAY PO. During the same period patient was treated with GEMZAR, PROCRIT, TARCEVA. Patient was hospitalized. Patient recovered.

Megace Side Effects Report #6063595-0
Megace side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 20, 2009. Female patient, 89 years of age, weighting 102.0 lb, was diagnosed with decreased appetite and was treated with Megace. After drug was administered, patient experienced the following side effects: abasia, asthenia, condition aggravated, confusional state, epistaxis, mobility decreased. Megace dosage: unknown. During the same period patient was treated with ANTIGLAUCOMA PREPARATIONS AND MIOTICS. Patient recovered.


Megace Side Effects Report #4596119-5
Megace side effect was reported by a Consumer or non-health professional from on Feb 10, 2005. Female patient, 54 years of age, weighting 122.6 lb, was diagnosed with decreased appetite and was treated with Megace. After drug was administered, patient experienced the following side effects: abdominal pain , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cortisol abnormal, condition aggravated, haemoglobin decreased, mean cell volume increased, osteoporosis , spinal compression fracture. Megace dosage: 400 MG TWICE DAILY (NR), PO. During the same period patient was treated with PHENYTOIN, WARFARIN. Patient recovered.

Megace Side Effects Report #5274728-8
Megace side effect was reported by a Physician from UNITED STATES on Mar 06, 2007. Female patient, 83 years of age, weighting 134.3 lb, was diagnosed with appetite disorder, oral intake reduced and was treated with Megace. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, condition aggravated, white blood cell count increased. Megace dosage: 625 MG QDAY PO. During the same period patient was treated with MEGACE ES, PROGESTERONE, IRON SUPPLEMENT, ATENOLOL. Patient was hospitalized. Patient died on 02/23/2007.

Megace Side Effects Report #4754766-1
Megace side effect was reported by a Health Professional from UNITED STATES on Aug 26, 2005. Male patient, 79 years of age, weighting 130.0 lb, was diagnosed with neoplasm malignant, weight decreased and was treated with Megace. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , anorexia, asthenia, bladder obstruction, condition aggravated, constipation , dehydration. Megace dosage: 20 ML (800MG) PO QD. During the same period patient was treated with TERAZOSIN, LISINOPRIL, TRIMETH. Patient was hospitalized. Patient recovered.